This inventor holds 1 USPTO granted patent. Top assignee: Biogen, Incorporated. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations of Xiao-Qiang Qin in Gene Therapy
Introduction
Xiao-Qiang Qin is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of gene therapy, particularly in the development of methods and compositions for therapies using genes encoding secreted proteins. His work has the potential to impact the treatment of various diseases through innovative approaches.
Latest Patents
Xiao-Qiang Qin holds 1 patent related to his research. The patent is titled "Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta." This invention provides methods and pharmaceutical compositions for modifying cells of a mammalian recipient with DNA encoding a secreted protein, such as human interferon, in situ. The methods include forming a secreted protein expression system either in vivo or ex vivo and administering this expression system to the mammalian recipient. This innovative approach is useful for the localized and systemic delivery of interferons in situ.
Career Highlights
Xiao-Qiang Qin is currently associated with Biogen, Incorporated, a leading biotechnology company. His work at Biogen focuses on advancing therapeutic solutions that leverage genetic engineering and protein expression systems. His expertise in this area has positioned him as a key contributor to the company's research initiatives.
Collaborations
Xiao-Qiang Qin collaborates with various professionals in the field, including his coworker James G Barsoum. These collaborations enhance the research and development efforts at Biogen, fostering innovation and the advancement of gene therapy techniques.
Conclusion
Xiao-Qiang Qin's contributions to gene therapy through his innovative patent and work at Biogen highlight the importance of research in developing new therapeutic methods. His efforts are paving the way for advancements in medical treatments that utilize genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
